Skip to content

Clinical trials

Phase 2 Hemorrhage trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 2 Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20171
20181
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University2
Church & Dwight Company, Inc.1
GlaxoSmithKline1
Ottawa Hospital Research Institute1
Regeneron Pharmaceuticals1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage7
Atrial Fibrillation2
Venous Thromboembolism2
Dental Plaque1
Gingivitis1
Heart Valve Diseases1
Hematologic Neoplasms1
Spinal Cord Injuries1
Stroke1
Telangiectasia, Hereditary Hemorrhagic1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.